Search Results - "Grubbs, Gabrielle"

Refine Results
  1. 1

    Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits by Ravichandran, Supriya, Coyle, Elizabeth M, Klenow, Laura, Tang, Juanjie, Grubbs, Gabrielle, Liu, Shufeng, Wang, Tony, Golding, Hana, Khurana, Surender

    Published in Science translational medicine (01-07-2020)
    “…Multiple vaccine candidates against SARS-CoV-2 based on viral spike protein are under development. However, there is limited information on the quality of…”
    Get more information
    Journal Article
  2. 2

    Antibody affinity and cross-variant neutralization of SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 following third mRNA vaccination by Bellusci, Lorenza, Grubbs, Gabrielle, Zahra, Fatema Tuz, Forgacs, David, Golding, Hana, Ross, Ted M., Khurana, Surender

    Published in Nature communications (08-08-2022)
    “…There is limited knowledge on durability of neutralization capacity and antibody affinity maturation generated following two versus three doses of SARS-CoV-2…”
    Get full text
    Journal Article
  3. 3

    Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients by Tang, Juanjie, Ravichandran, Supriya, Lee, Youri, Grubbs, Gabrielle, Coyle, Elizabeth M., Klenow, Laura, Genser, Hollie, Golding, Hana, Khurana, Surender

    Published in Nature communications (22-02-2021)
    “…Hospitalized COVID-19 patients often present with a large spectrum of clinical symptoms. There is a critical need to better understand the immune responses to…”
    Get full text
    Journal Article
  4. 4

    Monoclonal antibodies targeting sites in respiratory syncytial virus attachment G protein provide protection against RSV-A and RSV-B in mice by Lee, Youri, Klenow, Laura, Coyle, Elizabeth M., Grubbs, Gabrielle, Golding, Hana, Khurana, Surender

    Published in Nature communications (04-04-2024)
    “…Currently, only Palivizumab and Nirsevimab that target the respiratory syncytical virus (RSV) fusion protein are licensed for pre-treatment of infants…”
    Get full text
    Journal Article
  5. 5

    Longitudinal proteome-wide antibody profiling in Marburg virus survivors identifies wing domain immunogen for vaccine design by Khurana, Surender, Grubbs, Gabrielle, Ravichandran, Supriya, Cluff, Emily, Kim, JungHyun, Kuehne, Ana I., Zak, Samantha, Dye, John M., Lutwama, Julius J., Herbert, Andrew S.

    Published in Nature communications (17-09-2024)
    “…Limited knowledge exists on the quality of polyclonal antibody responses generated following Marburg virus (MARV) infection and its evolution in survivors. In…”
    Get full text
    Journal Article
  6. 6

    Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children by Bellusci, Lorenza, Grubbs, Gabrielle, Sait, Shaimaa, Yonker, Lael M., Randolph, Adrienne G., Novak, Tanya, Kobayashi, Takuma, Khurana, Surender

    Published in Nature communications (01-12-2023)
    “…Emergence of highly transmissible Omicron subvariants led to increased SARS-CoV-2 infection and disease in children. However, minimal knowledge exists…”
    Get full text
    Journal Article
  7. 7

    Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern by Tang, Juanjie, Lee, Youri, Ravichandran, Supriya, Grubbs, Gabrielle, Huang, Chang, Stauft, Charles B., Wang, Tony, Golding, Basil, Golding, Hana, Khurana, Surender

    Published in iScience (24-09-2021)
    “…Hyperimmune immunoglobulin (hCoV-2IG) generated from SARS-CoV-2 convalescent plasma (CP) are under evaluation in clinical trials. Here we explored the antibody…”
    Get full text
    Journal Article
  8. 8

    Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex by Tang, Juanjie, Grubbs, Gabrielle, Lee, Youri, Huang, Chang, Ravichandran, Supriya, Forgacs, David, Golding, Hana, Ross, Ted M, Khurana, Surender

    Published in EBioMedicine (01-12-2021)
    “…Limited knowledge exists regarding antibody affinity maturation following mRNA vaccination in naïve vs. COVID-19 recovered individuals and potential sex…”
    Get full text
    Journal Article
  9. 9

    Evolution of the Antigenic Landscape in Children and Young Adults with COVID-19 and MIS-C by Bellusci, Lorenza, Grubbs, Gabrielle, Sait, Shaimaa, Herbst, Katherine W, Salazar, Juan C, Khurana, Surender, The Connecticut Children's Covid Collaborative

    Published in Vaccines (Basel) (07-06-2024)
    “…There is minimal knowledge regarding the durability of neutralization capacity and level of binding antibody generated against the highly transmissible…”
    Get full text
    Journal Article
  10. 10

    Glycosylation of H4 influenza strains with pandemic potential and susceptibilities to lung surfactant SP-D by Parsons, Lisa M, Zoueva, Olga, Grubbs, Gabrielle, Plant, Ewan, Jankowska, Ewa, Xie, Yijia, Song, Hao, Gao, George F, Ye, Zhiping, Khurana, Surender, Cipollo, John F

    Published in Frontiers in molecular biosciences (13-06-2023)
    “…We recently reported that members of group 1 influenza A virus (IAV) containing H2, H5, H6, and H11 hemagglutinins (HAs) are resistant to lung surfactant…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Impact of Convalescent Plasma Therapy on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Profile in Coronavirus Disease 2019 (COVID-19) Patients by Tang, Juanjie, Grubbs, Gabrielle, Lee, Youri, Golding, Hana, Khurana, Surender

    Published in Clinical infectious diseases (29-01-2022)
    “…Abstract Convalescent plasma (CP) have been used for treatment of coronavirus disease 2019 (COVID-19), but their effectiveness varies significantly. Moreover,…”
    Get full text
    Journal Article
  13. 13

    Neutralization of SARS-CoV-2 Omicron and other variants in serum from children with vaccination-induced myocarditis by Zahra, Fatema Tuz, Grubbs, Gabrielle, Dummer, Kirsten, Tremoulet, Adriana H., Shimizu, Chisato, Burns, Jane C., Khurana, Surender

    Published in Clinical infectious diseases (21-04-2022)
    “…Our study demonstrates that children who developed SARS-CoV-2 vaccination-induced myocarditis and may not receive another vaccination, could be susceptible to…”
    Get full text
    Journal Article
  14. 14
  15. 15

    SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19 by Ravichandran, Supriya, Tang, Juanjie, Grubbs, Gabrielle, Lee, Youri, Pourhashemi, Sara, Hussaini, Laila, Lapp, Stacey A., Jerris, Robert C., Singh, Vidisha, Chahroudi, Ann, Anderson, Evan J., Rostad, Christina A., Khurana, Surender

    Published in Nature immunology (01-11-2021)
    “…There is limited understanding of the viral antibody fingerprint following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children…”
    Get full text
    Journal Article
  16. 16

    Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron and Other Variants in Serum From Children With Vaccination-Induced Myocarditis by Zahra, Fatema Tuz, Grubbs, Gabrielle, Dummer, Kirsten, Tremoulet, Adriana H, Shimizu, Chisato, Burns, Jane C, Khurana, Surender

    Published in Clinical infectious diseases (29-10-2022)
    “…Our study demonstrates that children who developed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination-induced myocarditis and may not…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20